Update to ESC/EAS recommendations for dyslipidemia: what‘s new?
Authors:
Kristýna Čillíková
Authors‘ workplace:
Česká společnost pro aterosklerózu
Published in:
AtheroRev 2025; 10(3): 196-198
Category:
Sources
Mach F, Koskinas KC, Roeters van Lennep JE et al. 2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias: Developed by the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 2025, 46(42): 4359–4378. Dostupné z DOI: <https://doi.org/10.1093/eurheartj/ehaf190>.
Visseren FLJ, Mach F, Smulders YM et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2021; 42(34): 3227–3337. Dostupné z DOI: <http://doi: 10.1093/eurheartj/ehab484>.
Bueno H, Deaton C, Farrero M et al. 2025 ESC Clinical Consensus Statement on mental health and cardiovascular disease: developed under the auspices of the ESC Clinical Practice Guidelines Committee. Eur Heart J 2025; 46(41): 4156–4225. Dostupné z DOI: <http://doi: 10.1093/eurheartj/ehaf191>.
Labels
Angiology Diabetology Internal medicine Cardiology General practitioner for adultsArticle was published in
Athero Review
2025 Issue 3
- Advances in the Treatment of Myasthenia Gravis on the Horizon
- Hope Awakens with Early Diagnosis of Parkinson's Disease Based on Skin Odor
- Memantine in Dementia Therapy – Current Findings and Possible Future Applications
- Memantine Eases Daily Life for Patients and Caregivers
- Possibilities of Using Metamizole in the Treatment of Acute Primary Headaches
Most read in this issue
- Cardio-renal-metabolic syndrome: statement by the Czech Society for Atherosclerosis Committee – year 2025
- Comprehensive lipid-lowering therapy and cardiovascular risk reduction: a case report
- The event is not a coincidence, or the need for long-term and effective cardiovascular risk control
- Research on remarkable articles from international literature